This study is not yet accepting patients

Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis

a study on Cirrhosis Fibrosis Frailty Sarcopenia Exercise

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
study ends around
Principal Investigator
by Jennifer Lai, MD, MBA
Headshot of Jennifer Lai
Jennifer Lai

Description

Summary

Frailty and muscle health are important for patients with chronic liver disease. This study looks at the use of a digital prehabilitation app (HEAL-ME) plus creatine and whey protein combination supplementation on maintaining muscle health in patients with liver disease. The investigators anticipate that this combination of supplementation and nutrition/exercise prehabilitation app will maintain muscle health in patients with liver disease.

Official Title

Physical Prehabilitation With and Without Creatine/Whey Protein Supplementation Effects on Frailty In Patients With Cirrhosis

Keywords

Cirrhosis, Frailty, Sarcopenia, liver, muscle, creatine, whey protein, Fibrosis, Exercise, Nutritional Status, Whey, HEAL-ME digital app, Creatine supplementation, Whey protein supplementation, HEAL-ME and creatine/whey protein supplementation

Eligibility

You can join if…

Open to people ages 18 years and up

  • Confirmed diagnosis of cirrhosis by ICD-10 code, liver biopsy, abdominal imaging, or transient elastography
  • Access to digital device and internet at home
  • Ability to provide written informed consent before any study-related activities
  • Ability to remain in study for at least 3 months

You CAN'T join if...

  • Allergy to milk protein
  • On hemodialysis
  • No English language proficiency
  • Presence of condition or abnormality that in opinion of the Investigator will compromise safety of the patient or quality of the data
  • Concomitant severe underlying systemic illness that in the opinion of the Investigator would interfere with completion of study
  • Pregnant, breastfeeding, or intention of becoming pregnant during study time frame

Location

  • UCSF
    San Francisco California 94143 United States

Lead Scientist at UCSF

  • Jennifer Lai, MD, MBA
    Triple-board certified in transplant hepatology, physician nutrition, and integrative health, Dr. Lai is a practicing Integrative Hepatologist who specializes in caring for patients across the entire spectrum of liver disease, from pre-diagnosis to liver transplant.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT07029243
Study Type
Interventional
Participants
Expecting 100 study participants
Last Updated